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Coronary artery bypass grafting with the descend-
ing branch of the lateral femoral circumflex artery 
used as an arterial conduit: Is arteriographic evalu-
ation necessary before its use? 
To the Editor: 
We read with interest the recent paper by Schamun and 
associates l regarding the use of the descending branch of the 
lateral femoral circumflex artery (LFCA) as an arterial con-
duit for myocardial revascularization2 (Fig 1). We thoroughly 
agree with them because our clinical experience correlates 
with theirs. Since October 1997, the descending branch of the 
LFCA has been used as graft material in 24 patients who 
underwent coronary artery bypass grafting in our institution. 
In all cases, bilateral saphenous veins either were absent 
owing to bilateral stripping or were not.suitable as graft mate-
rial owing to varicose dilatation or fibrotic lesions. Twenty 
patients were men and 4 were women with a mean age of 65 
± 5 years (range 52-81 years). One patient in whom the 
descending branch of the left LFCA was used to revascularize 
the circumflex artery underwent redo coronary artery bypass 
grafting I month later because of a significant stenosis distal 
Fig 1. Bilateral femoral arteriography showing the adequately 
developed descending branch of the lateral femoral circum-
flex artery on both sides (black arrows). 
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to the anastomosis of the left internal thoracic artery (ITA) to 
the left anterior descending artery (LAD). The descending 
branch of the right LFCA was then used to revascularize the 
LAD distal to the stenosis. The descending branch of the 
Fig 2A. The poorly developed descending branch of the left 
lateral femoral circumflex artery (white arrowheads). 
Fig 2B. The well-developed descending branch of the left lat-
eral femoral circumflex artery (black arrows) contributing to 
the collateral circulation of the limb in the presence of occlu-
sive lesions of the left superficial femoral artery and the deep 
femoral artery after the origin of the lateral femoral circum-
flex artery. 
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LFCA was anastomosed on the right coronary artery in 10 
cases, the first marginal branch of the circumflex artery in 5, 
the first diagonal branch in 5, the LAD in 3, the intermediary 
artery in 1, and the posterior descending artery in another 
case. In 21 cases, proximal anastomoses of the descending 
branch of the LFCA were carried out on the ascending aorta, 
and in 4 cases they were carried out either on the pedunculat-
ed right ITA or left ITA, forming a Y-shaped graft. The aver-
age length of the descending branch of the LFCA was 16 cm 
(range 14-20 cm). Clinical follow-up was complete for all 
patients with a mean follow-up of 8 months (range 2-26 
months). One patient who was operated on on an urgent basis 
with an ejection fraction of 20% died of irreversible left ven-
tricular failure on the fifth postoperative day. A postoperative 
coronary angiogram was repeated in 4 patients, and in only 1 
of them was the descending branch of the LFCA found to be 
occluded. The other patients continue to be followed-up by 
periodic treadmill tests and remain clinically free of symp-
toms. During the beginning of our experience with the 
descending branch of the LFCA, we observed that this artery 
was unsuitable for use in some cases. The presence of a poor-
ly developed artery (Fig 2A) and of macroscopic atheroma-
tous lesions in the artery itself preclude its harvesting. For 
these reasons, we considered it necessary to perform bilateral 
femoral arteriography before surgery, during coronary 
angiography, for patients in whom the 'use of the descending 
branch of the LFCA might be justified. Arteriographic evalu-
ation provided further information on the anatomic variations 
of this artery such as the LFCA arising from the common 
femoral artery or a hypoplastic LFCA being sometimes 
replaced by small branches taking their origin from the deep 
or superficial femoral arteries. The anatomy of the LFCA can 
be different between the right and left sides in the same per-
son. Moreover, radiologic evaluation allows the detection of 
some occlusive or stenotic lesions of the superficial femoral 
arteries . for which the descending branch of the LFCA con-
tributes to the collateral circulation of the limb (Fig 2B). 
Histopathologic examination of the harvested descending 
branches of the LFCA revealed that this artery can contain 
macroscopically occult atheromatous lesions, sometimes even 
with microscopic calcified deposits, which could result in ear-
lier occlusion of the graft after the operation. 
In conclusion, although we totally agree with the conclu-
sions reported by the authors regarding this new arterial con-
duit, we would like to emphasize the importance of a preoper-
ative bil;1teral arteriographic evaluation of the femoral arteries 
and thatiof LFCAs, as we systematically do for thoracic arter-
ies. We believe that this evaluation can avoid useless attempts 
at harvesting. Attractiveness of the descending branch of the 
LFCA as an arterial conduit will depend on its patency rate in 
the lon$ term and the enthusiasm of surgeons to use it. 
Bernard Faidutti, MD 
Afksendiyos Kalangos, MD, PhD 
Clinic for Cardiovascular Surgery 
University Cantonal Hospital of Geneva 
1211 Geneva 14, Switzerland 
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A successful treatment of serous leakage from a 
polytetrafluoroethylene Blalock-Taussig shunt with 
intravenous fibrinogen administration 
To the Editor: 
Occasionally, excessive serous fluid leakage occurs as a 
complication after the modified polytetrafluoroethylene 
(PTFE) Blalock-Taussig (B-T) shunt. The estimated frequen-
cy of this complication is reported as approximately 20%,1,2 
but the mechanism is not clearly defined. We present a case of 
serous leakage through a modified B-T shunt treated with 
intravenous fibrinogen administration and describe our 
hypothesis about the role of fibrinolysis in this problem. 
A 3-year-old boy (11.5 kg) with single right ventricle and 
pulmonary stenosis was admitted for the treatment of cyanosis 
and exercise intolerance. A blood test revealed polycythemia 
with a hemoglobin level of 20.8 g/dL. We decided not to pro-
ceed directly to a Fontan procedure because of the lack of 
direct measurement of pulmonary arterial pressure and pul-
monary vascular resistance (the catheter did not go through 
the narrow ventricular outflow tract). As a preparation for a 
Fontan-type procedure, the boy underwent a left modified B-
T shunt with a 5-mm PTFE shunt. Anticoagulation was initi-
ated on the first postoperative day with a continuous heparin 
infusion (200 unitsfkg per day; Novo Heparin, Hoechst 
Marion Roussel, AG, Frankfurt, Germany) and an oral admin-
istration of ticlopidine hydrochloride (5 mgfkg per day; 
Panaldine, Dai-Ichi, Inc, Tokyo, Japan). On the third postop-
erative day, the chest tube drainage increased appreciably and 
the anticoagulation therapy was discontinued. The drainage 
continued for more than a week, with excessive serous fluid 
losses averaging 700 mL daily. The blood test revealed a 
marked decrease in total plasma protein (4.2 g/dL) and plas-
ma fibrinogen (93.6 mg/dL) levels. The massive leakage con-
tinued and plasma protein and fibrinogen did not increase 
despite the infusion of packs of frozen plasma. We adminis-
tered fibrinogen (heated and freeze-dried human fibrinogen; 
Fibrinogen HT, Yoshitomi, Inc, Osaka, Japan) intravenously, 
200 mgfkg per day, for 2 days. The leakage stopped instantly 
and the fibrinogen level increased to more than 300 mg/dL. 
The chest tube was removed and the patient was discharged 
after a catheterization. Anticoagulation therapy was never 
resumed. 
Three weeks later, the boy was readmitted with dyspnea, 
chest pain, and increasing cyanosis. A chest x-ray film 
revealed a massive pleural effusion on the left side, and a 
